Lab Technician Molecular and Cellular Immunology

VIB is an entrepreneurial and vibrant non-profit research institute in Flanders-Belgium with a clear focus on groundbreaking research in life sciences. About 1500 scientists and technologists from over 60 countries are based at the 5 Flemish Universities of Ghent, Leuven, Antwerp, Brussels, and Hasselt, and are studying the broad spectrum of molecular mechanisms that regulate the functions of the human body, plants and microorganisms.

The VIB Center for Inflammation Research (IRC) is mostly located at the Tech Lane Ghent Science Park of Ghent University, with two affiliated labs located on the VUB campus Etterbeek (Lab of Dendritic Cell Biology and Cancer Immunotherapy and Myeloid Cell Immunology Lab). The Center is focused on the molecular mechanisms of inflammation in pathologies such as allergy, autoimmune diseases, cancer, infectious diseases and senescence. At the heart of this research is the investigation of inter- and intracellular signaling pathways in innate and adaptive immune cells and barrier cells of the skin, lung and gut. IRC is currently composed of 17 independent research groups, with strong links to University Hospitals and collaborations with biotech companies to promote translational research and to bring novel findings closer to the patient.

The Lab of Dendritic Cell Biology and Cancer Immunotherapy is located in the city center of Brussels (campus Etterbeek, VUB), the international capital of Belgium and Europe. Our lab is composed of a dynamic team of about 15 researchers, with a good balance between young and more experienced scientists, performing cutting-edge onco-immunology research with a special focus on the dendritic cells in the tumor microenvironment. We exploit in vivo mouse models, (single cell) omics, multi-colour spectral flow cytometry, lipid nanoparticle technology and other cutting-edge approaches to gain groundbreaking insights into the function of dendritic cells in tumors and how to use these cells for therapeutic interventions. Our work is published in high-profile journals such as Nature Communications, Cancer Research, Journal of Immunotherapy of Cancer and others. We are internationally recognized for our work and collaborate with several partners in Belgium and abroad.

The VIB Lab of Dendritic Cell Biology and Cancer Immunotherapy , headed by Prof Damya Laoui, is looking for a motivated research technician for a temporary contract of 6 months. The Laoui team focuses on the characterization of dendritic cells in the tumor microenvironment, research in which the candidate will be strongly involved and supportive. The lab offers a dynamic and scientifically stimulating working environment within an international, enthusiastic and motivated team.

• The candidate should hold a bachelor's degree (or higher) in biomedical, biochemical, biotechnological laboratory techniques or related fields.
• General experience in cell culture
• General experience in animal handling and husbandry background, FELASA B certificate is a strict requirement
• Specialized experience with animal experimental procedures, mouse genotyping, flow cytometry, ELISA, immunohistochemistry, microscopy or quantitative PCR is a strong bonus
• Good practical knowledge of English
• Basic computer skills (text processing, spreadsheet, etc.)
• Willing to learn new techniques and expand your knowledge
• Willing to participate in the general lab organization
• Able to work in team as well as individually
• Strong sense of pro-active and results-oriented attitude, highly organized and structured, detail-oriented lab worker with good interpersonal and communication skills

• Full-time job offer
• Contract of fixed duration (6 months, with a possibility of prolongation)
• Start as from 1 September 2024

Motivated candidates are encouraged to apply online via the VIB application tool. Please include your CV, preferably with contact information for 1 or 2 referees, and a motivation letter.

For inquiries or more information, please contact Prof. Dr. Ir. Damya Laoui and Dr. Sofie Deschoemaeker, e-mail: [email protected] , [email protected]